SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-055572
Filing Date
2020-10-22
Accepted
2020-10-22 16:31:24
Documents
1
Period of Report
2020-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12196
  Complete submission text file 0001209191-20-055572.txt   13831
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Reporting) CIK: 0001388325 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39617 | Film No.: 201255212

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Issuer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)